Anti-anxiety drug may help nix heart attacks.

Alprazolam, an anti-anxiety drug sold under the trade name Xanax, may do more than just calm you. Coronary researcher John D. Folts -- whose animal experiments in the mid-1970s showed that aspirin could prevent the arterial blood clots that lead to heart attacks -- now reports animal results suggesting that alprazolam adds to aspirin's ability to stave off such clots.

In 1978, Folts and his co-workers at the University of Wisconsin-Madison, discovered that giving aspirin to dogs with narrowed coronary arteries did not prevent heart attacks if the dogs also had high blood levels of the hormone epinephrine. He found that epinephrine contributed to heart attack risk by promoting the aggregation of platelets, the blood cells that drive clotting.

Aspirin helps prevent blood clotting by binding to a specific receptor on the platelet surface. But it does nothing to reduce anxiety-driven heart attacks, because epinephrine -- the "fight-or-flight" hormone associated with anxiety -- does not act on platelets through the same receptor, Folts explains.

His team has now tested alprazolam and 10 dogs treated with aspirin for several days and then given an infusion of epinephrine. Only one dog developed clotting in the coronary arteries (coronary thrombosis), Folts reports. But when the same dogs received only aspirin before the epinephrine infusion, seven of the 10 developed the heart-threatening blood clots. Similarly, dogs given only alprazolam alone showed no reduction in coronary thrombosis.

Aspirin plus alprozolam "apparently shows complete protection" from heart-attack-causing blood clots, Folts asserts. Alprazolam's protective effect does not result solely from its mood-calming capacilities, he maintains, citing studies at the University of Texas Southern Medical Center in Dallas, in which aspirin combined with the sedative diazepam (Valium) did not ward off coronary thrombosis in patients recovering from heart attacks. Folts suggests that alprazolam acts by blocking platelet-activating factor, a clot-inducing protein produced by cells lining the blood vessels.